Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Krieg, C. Mahotka, T. Krieg, H. Grabsch, W. Müller, S. Takeno, C. Suschek, M. Heydthausen, H. Gabbert, C. Gerharz (2002)
Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progressionBritish Journal of Cancer, 86
Y. Ashhab, A. Alian, A. Polliack, A. Panet, D. Yehuda (2001)
Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution patternFEBS Letters, 495
I. Crnković-Mertens, F. Hoppe-Seyler, K. Butz (2003)
Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP geneOncogene, 22
G. Kasof, B. Gomes (2001)
Livin, a Novel Inhibitor of Apoptosis Protein Family Member*The Journal of Biological Chemistry, 276
P. Gazzaniga, A. Gradilone, L. Giuliani, O. Gandini, I. Silvestri, I. Nofroni, G. Saccani, L. Frati, A. Aglianó (2003)
Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer.Annals of oncology : official journal of the European Society for Medical Oncology, 14 1
Claudia Chen, H. Okayama (1987)
High-efficiency transformation of mammalian cells by plasmid DNA.Molecular and cellular biology, 7 8
A. Yagihashi, K. Asanuma, D. Kobayashi, N. Tsuji, Yasuharu Shijubo, S. Abe, Y. Hirohashi, T. Torigoe, N. Sato, N. Watanabe (2005)
Detection of autoantibodies to livin and survivin in Sera from lung cancer patients.Lung cancer, 48 2
Qi-heng Yang, Robin Church-Hajduk, Jinyu Ren, Michelle Newton, Chunying Du (2003)
Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis.Genes & development, 17 12
H. Caldas, Laura Honsey, R. Altura (2005)
Survivin 2α: a novel Survivin splice variant expressed in human malignanciesMolecular Cancer, 4
T. Brummelkamp, R. Bernards, R. Agami (2002)
A System for Stable Expression of Short Interfering RNAs in Mammalian CellsScience, 296
G. Salvesen, C. Duckett (2002)
IAP proteins: blocking the road to death's doorNature Reviews Molecular Cell Biology, 3
D. Vučić, H. Stennicke, M. Pisabarro, G. Salvesen, V. Dixit (2000)
ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomasCurrent Biology, 10
B. Nachmias, Y. Ashhab, Vered Bucholtz, O. Drize, L. Kadouri, M. Lotem, T. Peretz, O. Mandelboim, D. Ben-yehuda (2003)
Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma.Cancer research, 63 19
C. Mahotka, M. Wenzel, E. Springer, H. Gabbert, C. Gerharz (1999)
Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.Cancer research, 59 24
K. Butz, N. Whitaker, C. Denk, A. Ullmann, C. Geisen, F. Hoppe-Seyler (1999)
Induction of the p53-target gene GADD45 in HPV-positive cancer cellsOncogene, 18
S. Fulda, W. Wick, M. Weller, K. Debatin (2002)
Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivoNature Medicine, 8
P. Southern, P. Berg (1982)
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.Journal of molecular and applied genetics, 1 4
D. Vučić, M. Franklin, H. Wallweber, K. Das, B. Eckelman, Hwain Shin, L. Elliott, S. Kadkhodayan, K. Deshayes, G. Salvesen, W. Fairbrother (2005)
Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.The Biochemical journal, 385 Pt 1
A. Yagihashi, K. Asanuma, N. Tsuji, T. Torigoe, N. Sato, K. Hirata, N. Watanabe (2001)
Detection of anti-livin antibody in gastrointestinal cancer patients.Clinical chemistry, 49 7
G. Evan, K. Vousden (2001)
Proliferation, cell cycle and apoptosis in cancerNature, 411
A. Yagihashi, T. Ohmura, K. Asanuma, D. Kobayashi, N. Tsuji, T. Torigoe, N. Sato, K. Hirata, N. Watanabe (2005)
Detection of autoantibodies to survivin and livin in sera from patients with breast cancer.Clinica chimica acta; international journal of clinical chemistry, 362 1-2
C. Schmitt (2003)
Senescence, apoptosis and therapy — cutting the lifelines of cancerNature Reviews Cancer, 3
M. Sanna, J. Correia, Odile Ducrey, Jongdae Lee, K. Nomoto, N. Schrantz, Q. Deveraux, R. Ulevitch (2002)
IAP Suppression of Apoptosis Involves Distinct Mechanisms: the TAK1/JNK1 Signaling Cascade and Caspase InhibitionMolecular and Cellular Biology, 22
F. Igney, P. Krammer (2002)
Death and anti-death: tumour resistance to apoptosisNature Reviews Cancer, 2
P. Liston, W. Fong, R. Korneluk (2003)
The inhibitors of apoptosis: there is more to life than Bcl2Oncogene, 22
H. Taubert, M. Kappler, M. Bache, F. Bartel, T. Köhler, C. Lautenschläger, K. Blümke, P. Würl, H. Schmidt, A. Meye, S. Hauptmann (2005)
Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patientsOncogene, 24
K. Butz, T. Ristriani, Arnd Hengstermann, C. Denk, M. Scheffner, F. Hoppe-Seyler (2003)
siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cellsOncogene, 22
Qiuping Zhang, Xiong Jei, Youxin Jin, Ju Wei, L. Chun, W. Jin, W. Qun, Liu Yan, Chunsong Hu, Mingzhen Yang, Qingping Gao, Kejian Zhang, Zhimin Sun, L. Qun, Junyan Liu, Jinquan Tan (2004)
CC Chemokine Ligand 25 Enhances Resistance to Apoptosis in CD4+ T Cells from Patients with T-Cell Lineage Acute and Chronic Lymphocytic Leukemia by Means of Livin ActivationCancer Research, 64
S. Fields, R. Sternglanz (1994)
The two-hybrid system: an assay for protein-protein interactions.Trends in genetics : TIG, 10 8
Hua Meng, Caide Lu, H. Mabuchi, N. Tanigawa (2004)
Prognostic significance and different properties of survivin splicing variants in gastric cancer.Cancer letters, 216 2
D. Vučić, K. Deshayes, H. Ackerly, M. Pisabarro, S. Kadkhodayan, W. Fairbrother, V. Dixit (2002)
SMAC Negatively Regulates the Anti-apoptotic Activity of Melanoma Inhibitor of Apoptosis (ML-IAP)*The Journal of Biological Chemistry, 277
D. Altieri (2003)
Validating survivin as a cancer therapeutic targetNature Reviews Cancer, 3
Hiromi Tanabe, A. Yagihashi, N. Tsuji, Yasuharu Shijubo, S. Abe, N. Watanabe (2004)
Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.Lung cancer, 46 3
D Hanahan, RA Weinberg (2000)
The hallmarks of cancerCell, 100
A. Badran, A. Yoshida, K. Ishikawa, T. Goi, A. Yamaguchi, T. Ueda, M. Inuzuka (2004)
Identification of a novel splice variant of the human anti-apoptopsis gene survivin.Biochemical and biophysical research communications, 314 3
Jiing‐Huey Lin, Gary Deng, Qihong Huang, J. Morser (2000)
KIAP, a novel member of the inhibitor of apoptosis protein family.Biochemical and biophysical research communications, 279 3
Livin (alternatively called ML-IAP or KIAP) is a cancer-associated member of the antiapoptotic inhibitor of apoptosis protein family. Two splicing variants of Livin, designated Livin α and Livin β, have been identified. The significance of these isoforms for Livin-mediated apoptosis inhibition is largely unclear. Using an isoform-specific RNA interference (RNAi) strategy, we silenced endogenous Livin expression in HeLa cells. We found that the targeted inhibition of Livin β, but not of Livin α, blocked the growth of HeLa cells in clonogenic survival assays. In addition, silencing of Livin β, but not of Livin α, sensitized HeLa cells to different proapoptotic stimuli such as UV irradiation, tumor necrosis factor α, or etoposide. These events were linked to activation of caspase-3 and increased poly(ADP-ribose) polymerase cleavage, specifically upon silencing of Livin β. The proapoptotic sensitization of HeLa cells upon RNAi-mediated silencing of the endogenous livin gene was specifically reverted by ectopic expression of Livin β but not of Livin α. We conclude that the Livin β isoform plays the key role for the antiapoptotic protection of HeLa cells by the livin gene. Our results show that the Livin isoforms can strongly differ in their functional significance for the antiapoptotic resistance of tumor cells. Studies evaluating Livin as a novel diagnostic and prognostic tumor marker should benefit from isoform-specific expression analyses.
Journal of Molecular Medicine – Springer Journals
Published: Dec 31, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.